The European Brain Council sends out a newsletter as well as an External Environmental Report that brings articles and projects of interest to the attention of its members. From these, the Neuropenews Editors identify those that are of interest for the Neuropenews readers.
Apply for Funding: IMI 2 – CALL 6 (Innovative Medicines Initiative)
IMI has launched its 6th Call for proposals under IMI 2, with topics on Big data (Alzheimer’s disease and cancer), respiratory infection, and medicines safety.
News on Health in Horizon 2020 (EU Association of Research and Technology Organization)
Follow the news on Health in Horizon 2020.
What’s next for Horizon 2020? (Science Business)
The Commission is dovetailing its political and policy priorities into the new Horizon 2020 research plans for 2016 – 2017.
Future Cases of Dementia among People Born in 2015 & the Dementia Drug Pipeline (Office of Health Economics)
A new analysis estimates that one in three people born in 2015 in the UK will develop dementia. A second analysis looks at dementia treatments currently in clinical development, and reveals that clinical development success rates for dementia drugs are consistently lower than those for other therapy areas.
Axovant rolls into Phase III with a risky Alzheimer’s gambit (FierceBiotech)
Delving into the depths of cortical space (European Commission)
How does our brain figure out where we are in relation to our surroundings? The EU-funded project SPACEBRAIN shed light on this and other questions by exploring specific neural cells in the brain.
First trial to stop Alzheimer’s before symptoms emerge (BBC)
Most research into dementia is about finding treatments for people who are already affected by symptoms.